Skip to main content

Table 2 ADMA and HOMA-IR according to angiographic CAD indices

From: Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study

 

Number of vessels diseased

 

1-vessel CAD ( n= 40)

2-vessel CAD ( n= 37)

3-vessel CAD ( n= 74)

P for trend

ADMA (μmol/L)

0.49 ± 0.10

0.52 ± 0.11

0.50 ± 0.10

0.3

HOMA-IR

3.3 (2.5–5.0)

3.5 (2.6–5.2)

3.0 (2.0–4.6)

0.6

 

Sullivan extent score

 
 

1st quartile ≤20

2nd quartile 21–29

3rd quartile 30–41

4th quartile >41

P for trend

ADMA (μmol/L)

0.48 ± 0.09

0.49 ± 0.08

0.52 ± 0.10

0.54 ± 0.11

0.004

HOMA-IR

3.0 (2.1–4.5)

3.1 (2.7–4.9)

3.5 (2.7–5.4)

3.1 (2.3–4.8)

0.2

 

Gensini score

 
 

1st quartile <15

2nd quartile 15–32

3rd quartile 33–64

4th quartile >64

P for trend

ADMA (μmol/L)

0.49 ± 0.10

0.51 ± 0.10

0.50 ± 0.11

0.52 ± 0.12

0.15

HOMA-IR

3.1 (2.1–4.6)

3.3 (2.6–5.1)

3.0 (2.2–5.2)

3.2 (2.5–4.8)

0.4

  1. Data are shown as mean ± SD or median (interquartile range).
  2. Abbreviations: ADMA asymmetric dimethylarginine, CAD coronary artery disease, GFR glomerular filtration rate, HOMA-IR homeostasis model assessment for insulin resistance.